Close Menu

NEW YORK (GenomeWeb) – Molecular Devices announced today that it has signed an agreement to help launch Cytena's CloneSelect single-cell printer in North America.

The printer uses microfluidics and real-time image analysis to isolate single cells and provide visual documentation of monoclonality for use in cell line development. It has particular use in antibody discovery, enabling the automated isolation of single cells into standard 96- and 384-well plates for a wide range of cell types, according to Molecular Devices.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A new analysis finds that nearly half the late-stage clinical trials sponsored by a US National Cancer Institute program influence patient care.

Technology Review reports that sickle cell patients are optimistic about gene editing to treat their disease, but are worried about how available it will be.

The owner of the GEDmatch website tells CBS12 he is considering charging law enforcement a fee to use the site.

In Nature this week: babies born by caesarean section are more likely to have altered gut microbiota profiles, and more.